Barclays »

Tonix Pharmaceuticals Hldg shares owned by Barclays

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg (TNXP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tonix Pharmaceuticals Hldg

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $301k 13k 24.16
2025-06-30 $478k 13k 35.94

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Tonix Pharmaceuticals Hldg

BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
State Street Corporation
Capital Fund Management
Millennium Management
UBS Group
FMR
Susquehanna International
Susquehanna Portfolio Strategies
Squarepoint Ops
Charles Schwab Investment Management
Wellington Management Company
XTX Topco

View all funds holding Tonix Pharmaceuticals Hldg